United States · FDA National Drug Code directory
Sumatriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-170_d0b56323-49ef-f239-e053-2a95a90ae766
- Product NDC
- 71921-170
- Form
- SPRAY
- Composition / generic term
- sumatriptan
- Labeler
- Florida Pharmaceutical Products, LLC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210515
- Source listing expiry
- 20261231
Source-listed ingredients
- SUMATRIPTAN — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CONTAINER in 1 BOX (71921-170-61) / 1 SPRAY in 1 CONTAINER · 71921-170-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →